These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30649229)

  • 1. Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.
    Van Gerwen M; Alpert N; Wolf A; Ohri N; Lewis E; Rosenzweig KE; Flores R; Taioli E
    Carcinogenesis; 2019 Jun; 40(4):529-536. PubMed ID: 30649229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
    Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
    Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of postoperative radiotherapy in the management of malignant pleural mesothelioma : A propensity score matching of the SEER database.
    Abdel-Rahman O
    Strahlenther Onkol; 2017 Apr; 193(4):276-284. PubMed ID: 28044200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
    Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
    Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
    PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.
    Linton A; Pavlakis N; O'Connell R; Soeberg M; Kao S; Clarke S; Vardy J; van Zandwijk N
    Br J Cancer; 2014 Oct; 111(9):1860-9. PubMed ID: 25188323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma.
    Barsky AR; Ahern CA; Venigalla S; Verma V; Anstadt EJ; Wright CM; Ludmir EB; Berlind CG; Lindsay WD; Grover S; Cengel KA; Simone CB
    Clin Lung Cancer; 2020 Nov; 21(6):e583-e591. PubMed ID: 32611504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
    Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
    Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
    Giroux Leprieur E; Hirata T; Mo M; Chen Z; Okamoto J; Clement G; Li H; Wislez M; Jablons DM; He B
    Lung Cancer; 2014 Sep; 85(3):465-71. PubMed ID: 25023662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
    Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
    Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection.
    Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Friedberg JS; Simone CB
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):758-766.e1. PubMed ID: 30454981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation.
    Hasan B; Greillier L; Pallis A; Menis J; Gaafar R; Sylvester R; Fennell DA; Baas P; Surmont V; Van Meerbeeck JP; O'brien ME
    Eur J Cancer; 2014 Nov; 50(16):2771-82. PubMed ID: 25155251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey.
    Ceresoli GL; Grosso F; Zucali PA; Mencoboni M; Pasello G; Ripa C; Degiovanni D; Simonelli M; Bruzzone A; Dipietrantonj C; Piccolini E; Beretta GD; Favaretto AG; Giordano L; Santoro A; Botta M
    Br J Cancer; 2014 Jul; 111(2):220-6. PubMed ID: 24918816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors affecting survival in malignant pleural mesothelioma: analysis of 125 subjects.
    Komurcuoglu B; Cirak AK; Kirakli SC; Polat G; Yucel N; Usluer O; Erer O; Balci G; Gayaf M; Guldaval F; Aktogu S; Guclu S; Ozsoz A; Halilcolar H
    Tumori; 2014; 100(1):55-9. PubMed ID: 24675492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women with malignant pleural mesothelioma have a threefold better survival rate than men.
    Taioli E; Wolf AS; Camacho-Rivera M; Flores RM
    Ann Thorac Surg; 2014 Sep; 98(3):1020-4. PubMed ID: 24928677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.
    Gill RR; Yeap BY; Bueno R; Richards WG
    J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma.
    de Perrot M; Dong Z; Bradbury P; Patsios D; Keshavjee S; Leighl NB; Hope A; Feld R; Cho J
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.
    Nelson DB; Rice DC; Niu J; Atay S; Vaporciyan AA; Antonoff M; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao A; Gomez D; Giordano SH; Mehran R; Sepesi B
    J Clin Oncol; 2017 Oct; 35(29):3354-3362. PubMed ID: 28817374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.